LAVA MEDTECH ACQUISITION COR - CLASS A COM (LVAC)

CUSIP: 519345102

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / CLASS A COM
Total 13F shares
9,486,724
Share change
+405,391
Total reported value
$95,299,000
Price per share
$10.04
Number of holders
48
Value change
+$4,125,673
Number of buys
15
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 519345102?
CUSIP 519345102 identifies LVAC - LAVA MEDTECH ACQUISITION COR - CLASS A COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LAVA MEDTECH ACQUISITION COR - CLASS A COM (LVAC) as of Q3 2022

As of 30 Sep 2022, LAVA MEDTECH ACQUISITION COR - CLASS A COM (LVAC) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,486,724 shares. The largest 10 holders included Saba Capital Management, L.P., Polar Asset Management Partners Inc., Shaolin Capital Management LLC, Periscope Capital Inc., Governors Lane LP, Sculptor Capital LP, MARSHALL WACE, LLP, Balyasny Asset Management LLC, Westchester Capital Management, LLC, and TORONTO DOMINION BANK. This page lists 48 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.